相似文献
1
Large granular lymphocyte disorders: new etiopathogenetic clues as a rationale for innovative therapeutic approaches.
Haematologica. 2009 Oct;94(10):1341-5. doi: 10.3324/haematol.2009.012161.
2
Clinical Features, Pathogenesis, and Treatment of Large Granular Lymphocyte Leukemias.
Intern Med. 2017;56(14):1759-1769. doi: 10.2169/internalmedicine.56.8881. Epub 2017 Jul 15.
3
Mixed-phenotype large granular lymphocytic leukemia: a rare subtype in the large granular lymphocytic leukemia spectrum.
Hum Pathol. 2018 Nov;81:96-104. doi: 10.1016/j.humpath.2018.06.023. Epub 2018 Jun 24.
4
The root of many evils: indolent large granular lymphocyte leukaemia and associated disorders.
Hematol Oncol. 2010 Sep;28(3):105-17. doi: 10.1002/hon.917.
5
Laboratory diagnosis of large granular lymphocytic leukemia.
Lab Hematol. 2004;10(3):148-9.
6
Large Granular Lymphocyte Leukemia and Precapillary Pulmonary Hypertension.
Chest. 2020 Dec;158(6):2602-2609. doi: 10.1016/j.chest.2020.07.094. Epub 2020 Sep 10.
7
Analysis of a French cohort of patients with large granular lymphocyte leukemia: a report on 229 cases.
Haematologica. 2010 Sep;95(9):1534-41. doi: 10.3324/haematol.2009.018481. Epub 2010 Apr 7.
8
Advances in diagnosis and treatment of large granular lymphocyte syndrome.
Curr Opin Hematol. 2011 Jan;18(1):55-62. doi: 10.1097/MOH.0b013e328340dc12.
9
Dysfunction of immune system in the development of large granular lymphocyte leukemia.
Hematology. 2019 Dec;24(1):139-147. doi: 10.1080/10245332.2018.1535294. Epub 2018 Oct 18.
10
Pathophysiologic mechanisms and management of neutropenia associated with large granular lymphocytic leukemia.
Expert Rev Hematol. 2011 Jun;4(3):317-28. doi: 10.1586/ehm.11.26.
引用本文的文献
1
T Cell Repertoire Analysis as a Molecular Signature of the Spectrum of T-LGL Lymphoproliferative Disorders: Tracing the Literature.
Curr Issues Mol Biol. 2025 Apr 8;47(4):264. doi: 10.3390/cimb47040264.
2
A Novel Vaccine Strategy to Prevent Cytauxzoonosis in Domestic Cats.
Vaccines (Basel). 2023 Mar 2;11(3):573. doi: 10.3390/vaccines11030573.
3
All that glitters is not LGL Leukemia.
Leukemia. 2022 Nov;36(11):2551-2557. doi: 10.1038/s41375-022-01695-x. Epub 2022 Sep 15.
4
Defining TCRγδ lymphoproliferative disorders by combined immunophenotypic and molecular evaluation.
Nat Commun. 2022 Jun 8;13(1):3298. doi: 10.1038/s41467-022-31015-x.
5
Comparison of hematologic abnormalities between hospitalized coronavirus disease 2019 positive and negative patients with correlation to disease severity and outcome.
J Med Virol. 2022 Aug;94(8):3757-3767. doi: 10.1002/jmv.27793. Epub 2022 May 4.
6
Isolated anemia in patients with large granular lymphocytic leukemia (LGLL).
Blood Cancer J. 2022 Feb 22;12(2):30. doi: 10.1038/s41408-022-00632-6.
7
Neutropenia and Large Granular Lymphocyte Leukemia: From Pathogenesis to Therapeutic Options.
Cells. 2021 Oct 19;10(10):2800. doi: 10.3390/cells10102800.
8
Blood cell morphology and COVID-19 clinical course, severity, and outcome.
J Hematop. 2021 Jul 5;14(3):221-228. doi: 10.1007/s12308-021-00459-3. eCollection 2021 Sep.
9
Bone Marrow Failure Syndromes, Overlapping Diseases with a Common Cytokine Signature.
Int J Mol Sci. 2021 Jan 12;22(2):705. doi: 10.3390/ijms22020705.
10
Insights Into Genetic Landscape of Large Granular Lymphocyte Leukemia.
Front Oncol. 2020 Feb 18;10:152. doi: 10.3389/fonc.2020.00152. eCollection 2020.
本文引用的文献
1
Therapeutic implications of variable expression of CD52 on clonal cytotoxic T cells in CD8+ large granular lymphocyte leukemia.
Haematologica. 2009 Oct;94(10):1407-14. doi: 10.3324/haematol.2009.009191.
2
Interleukin-15 enhances proteasomal degradation of bid in normal lymphocytes: implications for large granular lymphocyte leukemias.
Cancer Res. 2009 May 1;69(9):3986-94. doi: 10.1158/0008-5472.CAN-08-3735. Epub 2009 Apr 14.
3
TSC-22 contributes to hematopoietic precursor cell proliferation and repopulation and is epigenetically silenced in large granular lymphocyte leukemia.
Blood. 2009 May 28;113(22):5558-67. doi: 10.1182/blood-2009-02-205732. Epub 2009 Mar 27.
4
Clonal expansion of T/NK-cells during tyrosine kinase inhibitor dasatinib therapy.
Leukemia. 2009 Aug;23(8):1398-405. doi: 10.1038/leu.2009.46. Epub 2009 Mar 19.
5
T-cell large granular lymphocyte leukemia associated with myelodysplastic syndrome: a clinicopathologic study of nine cases.
Am J Clin Pathol. 2009 Mar;131(3):347-56. doi: 10.1309/AJCP6YHI1JEXAWAP.
6
Natural killer or natural killer/T cell lineage large granular lymphocytosis associated with dasatinib therapy for Philadelphia chromosome positive leukemia.
Haematologica. 2009 Jan;94(1):135-9. doi: 10.3324/haematol.13151. Epub 2008 Dec 9.
7
Network model of survival signaling in large granular lymphocyte leukemia.
Proc Natl Acad Sci U S A. 2008 Oct 21;105(42):16308-13. doi: 10.1073/pnas.0806447105. Epub 2008 Oct 13.
8
Clinical improvement by farnesyltransferase inhibition in NK large granular lymphocyte leukemia associated with imbalanced NK receptor signaling.
Blood. 2008 Dec 1;112(12):4694-8. doi: 10.1182/blood-2008-02-136382. Epub 2008 Sep 12.
9
Expanded cells in monoclonal TCR-alphabeta+/CD4+/NKa+/CD8-/+dim T-LGL lymphocytosis recognize hCMV antigens.
Blood. 2008 Dec 1;112(12):4609-16. doi: 10.1182/blood-2008-03-146241. Epub 2008 Sep 2.
10
Long-term responses and outcomes following immunosuppressive therapy in large granular lymphocyte leukemia-associated pure red cell aplasia: a Nationwide Cohort Study in Japan for the PRCA Collaborative Study Group.
Haematologica. 2008 Oct;93(10):1555-9. doi: 10.3324/haematol.12871. Epub 2008 Jul 18.
Zotero 插件